🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
0.1440
+0.0040 (2.86%)
Nov 18, 2026, 4:00 PM EST - Market closed

Theriva Biologics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8.4713.0611.6123.1841.7967.33
Cash & Short-Term Investments
8.4713.0611.6123.1841.7967.33
Cash Growth
12.55%12.46%-49.91%-44.53%-37.93%981.18%
Other Receivables
1.673.843.321.940.23-
Receivables
1.673.843.321.940.23-
Prepaid Expenses
0.480.580.981.171.211.08
Other Current Assets
--0.371.122.290.46
Total Current Assets
10.6217.4716.2827.445.5268.86
Property, Plant & Equipment
1.861.031.542.181.541.48
Goodwill
---5.75.53-
Long-Term Deferred Charges
18.9619.6217.3619.7619.15-
Other Long-Term Assets
0.120.130.170.180.120.02
Total Assets
31.5638.2435.3555.2271.8670.37

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.471.010.860.770.920.52
Accrued Expenses
6.746.724.514.512.92.91
Current Portion of Long-Term Debt
0.030.060.060.060.06-
Current Portion of Leases
0.540.550.540.490.220.12
Other Current Liabilities
11.681.610.912.97-
Total Current Liabilities
8.7810.017.596.747.063.55
Long-Term Debt
1.631.670.090.160.22-
Long-Term Leases
1.230.350.871.441.191.4
Long-Term Deferred Tax Liabilities
----1.62-
Other Long-Term Liabilities
9.1810.827.747.187.21-
Total Liabilities
20.8122.8616.2915.5217.34.96

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.050.03000.020.01
Additional Paid-In Capital
376.3373.59355.5346.54343.75336.68
Retained Earnings
-365.44-358.71-334.97-309.32-290.97-271.28
Treasury Stock
-0.29-0.29-0.29-0.29-0.29-
Comprehensive Income & Other
0.140.76-1.180.03-0.68-
Total Common Equity
10.7515.3819.0736.9651.8365.41
Shareholders' Equity
10.7515.3819.0739.754.5665.41
Total Liabilities & Equity
31.5638.2435.3555.2271.8670.37

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
3.432.631.572.151.681.53
Net Cash (Debt)
5.0510.4310.0421.0240.1165.8
Net Cash Growth
5.88%3.81%-52.22%-47.58%-39.05%1043.52%
Net Cash Per Share
0.120.867.4532.6365.41134.97
Filing Date Shares Outstanding
45.8945.892.780.690.60.63
Total Common Shares Outstanding
45.8935.692.780.690.60.53
Working Capital
1.847.458.720.6738.4665.3
Book Value Per Share
0.230.436.8553.8985.67123.84
Tangible Book Value
10.7515.3819.0731.2646.3165.41
Tangible Book Value Per Share
0.230.436.8545.5876.54123.84
Machinery
-0.640.710.90.90.83
Leasehold Improvements
-0.090.090.090.090.09
SEC Filings: 10-K · 10-Q